Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2023-03-22 to 2026-06-30
ROUNDS
2
led 1, joined 1
LEAD SHARE · USD
$61.5M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
14
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2023-03-22 to 2026-06-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Flare Therapeutics A biotech startup targeting transcription factors | Series C Verified against 5 sources | $85M | 2026-06-30 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ LEAD ] |